BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25311495)

  • 41. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia.
    Sorour A; Ayad MW; Kassem H
    Genet Test Mol Biomarkers; 2013 Mar; 17(3):195-201. PubMed ID: 23397959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
    Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
    Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
    Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
    Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan.
    Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT
    Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. XRCC1 and XPD gene polymorphisms in a South Indian population.
    Vettriselvi V; Vijayalakshmi K; Solomon PF; Venkatachalam P
    Asian Pac J Cancer Prev; 2007; 8(2):283-6. PubMed ID: 17696747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
    Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
    Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG).
    Güven M; Unal M; Batar B; Eroğlu E; Devarnoğlu K; Tamçelik N; Uçar D; Sarici A
    Mol Vis; 2007 Jan; 13():12-7. PubMed ID: 17242676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
    Zhao F; Shang Y; Zeng C; Gao D; Li K
    Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi population, China.
    Long XD; Ma Y; Huang YZ; Yi Y; Liang QX; Ma AM; Zeng LP; Fu GH
    Mol Carcinog; 2010 Jun; 49(6):611-8. PubMed ID: 20232359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients.
    Dhangar S; Shanbhag V; Shanmukhaiah C; Vundinti BR
    Mol Biol Rep; 2019 Oct; 46(5):4997-5003. PubMed ID: 31286393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
    Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
    Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Polymorphism Lys751Gln of XPD gene and breast cancer risk in women].
    Romanowicz-Makowska H; Smolarz B
    Pol Merkur Lekarski; 2007 Aug; 23(134):107-9. PubMed ID: 18044339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between XPG gene polymorphisms and development of gastric cancer risk in a Chinese population.
    Feng YB; Fan DQ; Yu J; Bie YK
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.
    Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC
    J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia.
    Canalle R; Silveira VS; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
    Leuk Lymphoma; 2011 Jun; 52(6):1118-26. PubMed ID: 21463130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
    Nairuz T; Rahman M; Bushra MU; Kabir Y
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
    Ding DP; He XF; Zhang Y
    Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.
    Le Morvan V; Bellott R; Moisan F; Mathoulin-Pélissier S; Bonnet J; Robert J
    Pharmacogenomics; 2006 Sep; 7(6):843-52. PubMed ID: 16981845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.